Prescribing overview
Manufacturer-marketed oral and mobility support for dogs and cats; not an FDA-approved disease treatment.
Key prescribing checks
- Assess ingredient sensitivities, other supplements and the intended clinical goal before adding the product.
- It does not replace dental diagnosis, professional dental treatment or a patient-specific pain plan.
- Track objective response and review continued use with the veterinarian rather than assuming marketing claims apply to every patient.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs and cats
Supplement; manufacturer claims, not approved indicationsOral, mobility, skin/coat and recovery support
Supportive care does not replace dental assessment or a pain diagnosis.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
The manufacturer describes a proprietary beef-tallow fatty-acid mixture and proposes effects on inflammatory responses; clinical drug-like mechanisms are not established by this marketing page.
Absorption, distribution, metabolism and elimination
No species-specific quantitative absorption, distribution, metabolism or elimination data were verified in the reviewed product information.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Supplement safety information may be limited. A missing contraindication list does not establish safety in every species, during pregnancy, or with other treatments.
1-TDC
Manufacturer information for canine/feline proprietary supplement; not an approved-drug contraindication assessment.
Contraindications · when not to use
- The reviewed manufacturer page does not establish a complete contraindication list.
Precautions & monitoring
- Proprietary composition and marketing safety statements do not establish safety for every patient or concurrent medication.
Absence of listed contraindications is not evidence of no contraindications.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
A complete adverse-event profile is not supplied; absence of reported events is not proof of safety.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
No approved veterinary drug-dose regimen is established here for this supplement. Manufacturer serving directions are not equivalent to an evidence-based treatment protocol.
No approved veterinary drug regimen. Confirm the current package and veterinarian-directed supplement plan; capsule counts are not interchangeable with other presentations.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
1-TDC
Manufacturer information for canine/feline proprietary supplement; not an approved-drug contraindication assessment.
- Interaction restrictions are not established by the reviewed page.
Monitoring
Agree on measurable dental or mobility goals and reassess benefit and tolerability.
Client counseling
Continue professional dental care. Report unexpected illness and disclose all supplements.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the current container storage instructions; retain the ingredient panel and lot information.
Brands, formulations & ingredient identity
Active ingredients
Proprietary 1-Tetradecanol Complex fatty acid blend
Other searchable names: 1TDC · 1 TDC · I-TDC · 1-Tetradecanol Complex
Also searchable as I-TDC and 1TDC; verify the exact manufacturer product and complete ingredient panel.
The manufacturer describes a proprietary fatty-acid blend derived from beef tallow.
Products and presentations may contain additional oils and excipients; review the current package for its complete composition.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
1-TDC
- Formulation
- Pet fatty-acid supplement
- Label / product scope
- Dogs · Cats
Manufacturer describes oral and mobility support; verify current full ingredient panel.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →